NO871187L - Fremgangsmaate til fremstilling av en blanding inneholdende indometacin. - Google Patents

Fremgangsmaate til fremstilling av en blanding inneholdende indometacin.

Info

Publication number
NO871187L
NO871187L NO871187A NO871187A NO871187L NO 871187 L NO871187 L NO 871187L NO 871187 A NO871187 A NO 871187A NO 871187 A NO871187 A NO 871187A NO 871187 L NO871187 L NO 871187L
Authority
NO
Norway
Prior art keywords
preparation
procedure
mixture containing
indometacin
carboxylic acid
Prior art date
Application number
NO871187A
Other languages
English (en)
Other versions
NO871187D0 (no
Inventor
Kim Drummond Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummond Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford
Publication of NO871187D0 publication Critical patent/NO871187D0/no
Publication of NO871187L publication Critical patent/NO871187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO871187A 1986-03-27 1987-03-23 Fremgangsmaate til fremstilling av en blanding inneholdende indometacin. NO871187L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607662A GB8607662D0 (en) 1986-03-27 1986-03-27 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
NO871187D0 NO871187D0 (no) 1987-03-23
NO871187L true NO871187L (no) 1987-09-28

Family

ID=10595349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871187A NO871187L (no) 1986-03-27 1987-03-23 Fremgangsmaate til fremstilling av en blanding inneholdende indometacin.

Country Status (17)

Country Link
US (1) US4885279A (no)
EP (1) EP0239332B1 (no)
JP (1) JPS6322017A (no)
AT (1) ATE60993T1 (no)
AU (1) AU593084B2 (no)
CA (1) CA1285488C (no)
DE (1) DE3768110D1 (no)
DK (1) DK154887A (no)
ES (1) ES2038658T3 (no)
GB (1) GB8607662D0 (no)
GR (1) GR3001520T3 (no)
IE (1) IE59636B1 (no)
NO (1) NO871187L (no)
NZ (1) NZ219717A (no)
PH (1) PH25296A (no)
PT (1) PT84580B (no)
ZA (1) ZA872137B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
US5518738A (en) * 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
DE10352511A1 (de) * 2003-11-07 2005-06-16 Ernst-Moritz-Arndt-Universität Greifswald Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen
HU231309B1 (hu) 2014-02-25 2022-11-28 Darholding Kft. Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
EP0013783B1 (en) * 1979-01-12 1984-04-04 The Australian National University Protection of the gastric mucosal lining from damage by aspirin and related drugs
US4228161A (en) * 1979-03-28 1980-10-14 Merck & Co., Inc. Anti-inflammatory combination having reduced ulcerogenicity
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
GB2155329A (en) * 1984-03-08 1985-09-25 Kim Drummond Rainsford A pharmaceutical formulation containing azapropazone
HU195918B (en) * 1984-03-14 1988-08-29 Jerome Corbiere Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
ATE86110T1 (de) * 1984-12-20 1993-03-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
NO871187D0 (no) 1987-03-23
NZ219717A (en) 1989-06-28
AU593084B2 (en) 1990-02-01
EP0239332A3 (en) 1988-03-02
JPH0572887B2 (no) 1993-10-13
DK154887A (da) 1987-09-28
ATE60993T1 (de) 1991-03-15
DE3768110D1 (de) 1991-04-04
IE59636B1 (en) 1994-03-09
PT84580A (en) 1987-04-01
GB8607662D0 (en) 1986-04-30
PH25296A (en) 1991-04-30
PT84580B (pt) 1989-11-30
ZA872137B (en) 1987-10-28
GR3001520T3 (en) 1992-11-23
CA1285488C (en) 1991-07-02
JPS6322017A (ja) 1988-01-29
AU7071387A (en) 1987-10-01
DK154887D0 (da) 1987-03-26
US4885279A (en) 1989-12-05
IE870742L (en) 1987-09-27
ES2038658T3 (es) 1993-08-01
EP0239332B1 (en) 1991-02-27
EP0239332A2 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
MY102459A (en) Oral sustained release pharmaceutical preparation.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
AU7960287A (en) Prodrug derivatives of carboxylic acid drugs
IS1530B (is) Aðferð við framleiðslu á nýjum lyfjablöndum með tempraðri losun á virka efninu
NO922232L (no) Fysiologisk aktive, polypeptid-holdige, farmasoeytiske preparater
NO863670L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO165626C (no) Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol.
IT1223565B (it) Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
SE7413548L (no)
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO871187D0 (no) Fremgangsmaate til fremstilling av en blanding inneholdende indometacin.
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
IT8022724A0 (it) Di addizione con acidi compatibili anilidi di acidi dal punto di vista fisiologico e (3-alchilamminio-2-idrossipropossi)procedimento per la loro -furan-2-carbossilici e loro sali preparazione e anche prodotti medicinali che contengono questi composti.
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
GB1371939A (en) Pyridine carboxamides
EP0272057A3 (en) Pharmaceutical compositions containing pyranoquinolines
JPS6440426A (en) Antitumor agent
ES8403860A1 (es) Derivados del acido d-2-6(6-metoxi-2-naftil)-propionico.
ES8502436A1 (es) Procedimiento para la preparacion de n-(2-piridil)-(1,4-dimetil-5-(4-clorobenzoil))-2-pirrolacetamida.
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
NO810658L (no) Fremgangsmaate til fremstilling av salter av alkankarboksylsyre og farmasoeytiske preparater
IT8522978A0 (it) Estere dell'acido alfa-metil-4-(2-tienilcarbonil)benzenacetico avente attivita'mucosecretolitica, antiinfiammatoria, analgesica, antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.
JPS5246066A (en) Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts
SE8800888D0 (sv) Forfarande for framstellning av ett lekemedelspreparat for forebyggande och behandling av alkoholism